Developing technologies for efficient and scalable disruption of gene expression will provide powerful tools for studying gene function, developmental pathways, and disease mechanisms. Here, we develop clustered regularly interspaced short palindromic repeat interference (CRISPRi) to repress gene expression in human induced pluripotent stem cells (iPSCs). CRISPRi, in which a doxycycline-inducible deactivated Cas9 is fused to a KRAB repression domain, can specifically and reversibly inhibit gene expression in iPSCs and iPSC-derived cardiac progenitors, cardiomyocytes, and T lymphocytes. This gene repression system is tunable and has the potential to silence single alleles. Compared with CRISPR nuclease (CRISPRn), CRISPRi gene repression is more efficient and homogenous across cell populations. The CRISPRi system in iPSCs provides a powerful platform to perform genome-scale screens in a wide range of iPSC-derived cell types, dissect developmental pathways, and model disease.
Copyright © 2016 Elsevier Inc. All rights reserved.
Efficient and allele-specific genome editing of disease loci in human iPSCs.Mol Ther. 2015 Mar;23(3):570-7. doi: 10.1038/mt.2014.226. Epub 2014 Nov 24. Mol Ther. 2015. PMID: 25418680 Free PMC article.
Targeted Transcriptional Repression in Bacteria Using CRISPR Interference (CRISPRi).Methods Mol Biol. 2015;1311:349-62. doi: 10.1007/978-1-4939-2687-9_23. Methods Mol Biol. 2015. PMID: 25981485 Free PMC article.
CRISPR interference (CRISPRi) for sequence-specific control of gene expression.Nat Protoc. 2013 Nov;8(11):2180-96. doi: 10.1038/nprot.2013.132. Epub 2013 Oct 17. Nat Protoc. 2013. PMID: 24136345 Free PMC article.
Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.Exp Biol Med (Maywood). 2015 Aug;240(8):1065-70. doi: 10.1177/1535370215584932. Epub 2015 May 7. Exp Biol Med (Maywood). 2015. PMID: 25956682 Free PMC article. Review.
Site-Specific Genome Engineering in Human Pluripotent Stem Cells.Int J Mol Sci. 2016 Jun 24;17(7):1000. doi: 10.3390/ijms17071000. Int J Mol Sci. 2016. PMID: 27347935 Free PMC article. Review.
Cited by 92 articles
Modeling Psychiatric Disorder Biology with Stem Cells.Curr Psychiatry Rep. 2020 Apr 21;22(5):24. doi: 10.1007/s11920-020-01148-1. Curr Psychiatry Rep. 2020. PMID: 32318888 Review.
Gene editing and CRISPR in the clinic: current and future perspectives.Biosci Rep. 2020 Apr 30;40(4):BSR20200127. doi: 10.1042/BSR20200127. Biosci Rep. 2020. PMID: 32207531 Free PMC article.
Epigenetic Control of a Local Chromatin Landscape.Int J Mol Sci. 2020 Jan 31;21(3):943. doi: 10.3390/ijms21030943. Int J Mol Sci. 2020. PMID: 32023873 Free PMC article. Review.
Rewiring of endogenous signaling pathways to genomic targets for therapeutic cell reprogramming.Nat Commun. 2020 Jan 30;11(1):608. doi: 10.1038/s41467-020-14397-8. Nat Commun. 2020. PMID: 32001704 Free PMC article.
Two paralogous znf143 genes in zebrafish encode transcriptional activator proteins with similar functions but expressed at different levels during early development.BMC Mol Cell Biol. 2020 Jan 22;21(1):3. doi: 10.1186/s12860-020-0247-7. BMC Mol Cell Biol. 2020. PMID: 31969120 Free PMC article.
- P01 HL089707/HL/NHLBI NIH HHS/United States
- U01 HL098179/HL/NHLBI NIH HHS/United States
- R01-HL060664/HL/NHLBI NIH HHS/United States
- U01-GM09614/GM/NIGMS NIH HHS/United States
- P01-HL089707/HL/NHLBI NIH HHS/United States
- U01 HL099997/HL/NHLBI NIH HHS/United States
- T32 GM008284/GM/NIGMS NIH HHS/United States
- T32 GM007618/GM/NIGMS NIH HHS/United States
- T32 EB009383/EB/NIBIB NIH HHS/United States
- 1K12HD072222/HD/NICHD NIH HHS/United States
- R01HL130533/HL/NHLBI NIH HHS/United States
- U01-HL098179/HL/NHLBI NIH HHS/United States
- U01-HL099997/HL/NHLBI NIH HHS/United States
- U01 HL100406/HL/NHLBI NIH HHS/United States
- R01 HL108677/HL/NHLBI NIH HHS/United States
- R01 DA036858/DA/NIDA NIH HHS/United States
- R01-HL108677/HL/NHLBI NIH HHS/United States
- R01 HL130533/HL/NHLBI NIH HHS/United States
- 129844/Canadian Institutes of Health Research/Canada
- Howard Hughes Medical Institute/United States
- P30 AI027763/AI/NIAID NIH HHS/United States
- K12 HD072222/HD/NICHD NIH HHS/United States
- R01 HL060664/HL/NHLBI NIH HHS/United States
- T32 HL007544/HL/NHLBI NIH HHS/United States
- U01-HL100406/HL/NHLBI NIH HHS/United States